Skip to Content

SEC Filings

Filing date	Form	Description	View
Sep 20, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-250722.pdf 0001193125-19-250722.rtf 0001193125-19-250722.xls View HTML
Sep 20, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-250720.pdf 0001193125-19-250720.rtf 0001193125-19-250720.xls View HTML
Sep 19, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-249100.pdf 0001193125-19-249100.rtf 0001193125-19-249100.xls View HTML
Sep 19, 2019	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-19-249231.pdf 0001193125-19-249231.rtf 0001193125-19-249231.xls View HTML
Sep 19, 2019	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-19-249241.pdf 0001193125-19-249241.rtf 0001193125-19-249241.xls View HTML
Sep 05, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-238418.pdf 0001193125-19-238418.rtf 0001193125-19-238418.xls View HTML
Aug 26, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-229227.pdf 0001193125-19-229227.rtf 0001193125-19-229227.xls View HTML
Aug 22, 2019	DFAN14A	Additional proxy soliciting materials filed by non-management	0000921895-19-002303.pdf 0000921895-19-002303.rtf 0000921895-19-002303.xls View HTML
Aug 19, 2019	PRRN14A	Non-management revised preliminary proxy soliciting materials	0000921895-19-002270.pdf 0000921895-19-002270.rtf 0000921895-19-002270.xls View HTML
Aug 16, 2019	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-19-223186.pdf 0001193125-19-223186.rtf 0001193125-19-223186.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2021 Merrimack Pharmaceuticals.